-transparent.png){kind=logo}
In a prospective randomized clinical trial involving 150 patients who underwent major abdominal surgery, acetylsalicylic acid (ASA) and dihydroergotamine (DHE) were examined either alone or in combination for their potential to prevent thromboembolism. Combined treatment with ASA and DHE was found to be more effective in preventing the spread of thrombi and their propagation to the femoral veins.
Related Publications
F Zekert, and
M Schemper, and
K Neumann
January 2015,
Revista espanola de geriatria y gerontologia,
F Zekert, and
M Schemper, and
K Neumann
February 1984,
Orvosi hetilap,
F Zekert, and
M Schemper, and
K Neumann
December 1987,
Schweizerische medizinische Wochenschrift,
F Zekert, and
M Schemper, and
K Neumann
November 2006,
Medizinische Monatsschrift fur Pharmazeuten,
F Zekert, and
M Schemper, and
K Neumann
January 1978,
Seminars in thrombosis and hemostasis,
F Zekert, and
M Schemper, and
K Neumann
December 1987,
Drug intelligence & clinical pharmacy,
F Zekert, and
M Schemper, and
K Neumann
October 1981,
Die Medizinische Welt,
F Zekert, and
M Schemper, and
K Neumann
September 2015,
Experimental biology and medicine (Maywood, N.J.),
F Zekert, and
M Schemper, and
K Neumann
August 1968,
Journal of the Iowa Medical Society,
F Zekert, and
M Schemper, and
K Neumann
January 1982,
Arzneimittel-Forschung,
